Botanical species · safety record

Solenostemma argel

The EFSA Compendium of Botanicals holds 6 constituent measurements for Solenostemma argel. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Solenostemma argel (Delile) Hayne

6Constituent measurements

0Safety records

5Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Pregnane derivatives	Leaves	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Pregnane derivatives	Leaves	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Pregnane derivatives	Seed	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Alkaloids	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Phytic acid	Leaves	—	3.2 Gram/100 gram	Traditional analytical techniques (wet chemical tests)	No resolvable identifier
Tannins	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Mudawi, Mahmoud M. E., Chidrawar, Vijay R., Yassin, Abdelhadi Y. A., Habeballa, Rami S., Abd El-wahab, Mohammed F., Sulaiman, Mansour I. Analgesic activity of Solenostemma argel by modulating pain nociception pathway in mice. World Journal of Pharmaceutical Research, 2015, p. 187-197.
El-Kheir, M.K.S., Murwa, A.M. Chemical composition, minerals, protein fractionation, and anti-nutrition factors in leaf of hargel plant (Solenostemma Argel). European journal of scientific research, 2010, vol. 43, no. 3, p. 430-434.
Perrone, A., Plaza, A., Ercolino, SF., Hamed, AI., Parente, L., Pizza, C., Piacente, S. 14,15-secopregnane derivatives from the leaves of Solenostemma argel. JOURNAL OF NATURAL PRODUCTS, 2006, vol. 69, no. 1, p. 50-54. DOI
Hamed, AI. New steroids from Solenostemma argel leaves. FITOTERAPIA, 2001, vol. 72, no. 7, p. 747-755. DOI
Plaza, A., Perrone, A., Balestrieri, C., Balestrieri, ML., Bifulco, G., Carbone, V., Hamed, A., Pizza, C., Piacente, S. New antiproliferative 14,15-secopregnane glycosides from Solenostemma argel. TETRAHEDRON, 2005, vol. 61, no. 31, p. 7470-7480. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature